BioSpace News Archive

Combined with CDC guidelines, this new self monitoring tool aims to help schools reopen while keeping teachers, students, staff and families safe in the process

Cryoport, Inc., a global leader in life sciences supply chain solutions, and MEDIPAL HOLDINGS CORPORATION, Japan’s leading pharma wholesaler and distributor announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.

- Fireside chat will address KRAS inhibition and the promise of onvansertib as a new therapeutic option in colorectal cancer

American CryoStem Corporation is pleased to issue the following shareholder update letter from Chief Executive Officer John Arnone.

Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic use in the qualitative identification of the TIGIT protein by immunohistochemistry in formalin-fixed paraffin-embedded human tissues.

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), has historically been and remains a leader in the research and development of ampakines for a variety of central nervous system (CNS) disorders and cannabinoids for the treatment of sleep-related breathing disorders. On March 2, 2020, the Company and the UWM Research Foundation, Inc. (“UWMRF”), an affiliate of the University of Wisconsin-Milwaukee entered into an opti

With Multiple Applications for its Bone Adhesive Biomaterial under Development, the New Brand will Better Convey the Company’s Overall Goals and Objectives

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, announced that Bethany Dudek has joined the company as Vice President of Quality.

Shineco, Inc announced that the Board of Directors has appointed Dr. Fengming Liu as the new CEO and Chief Scientist to serve the Company’s strategic transformation, effective August 3, 2020.

Net Sales of $25.5 Million, an Increase of 123.4% Year-over-Year Provides Update on Orders for Personal Protective Equipment (PPE) Net sales for the second quarter of 2020 were $25.5 million, compared to $11.4 million for the second quarter of 2019, up 123.4% year-over-year. Net income for the second quarter of 2020 was $6.2 million, or $0.46 per diluted share, compared to $1.0 million, or $0.08 per diluted share, for the second quarter of 2019, up 475% on a per share basis. NOGAL